Quimiging, Lenie .

HRN: 11-72-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
METRONIDAZOLE 500MG (TAB)
09/26/2025
10/02/2025
IV
500mg
Q8h
Amoebiasis
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines